Council Members support both bottom-up and top-down value drivers critical to long/short equity investing. Taking a mosaic approach that considers multiple perspectives allows clients to have a deep, multi-dimensional view of companies, industries, and geographies.
GLG assists distressed investors who need to differentiate between dying industries, challenged capital structures, or management teams. Council Members contribute industry-specific inputs to inform asset valuations and help clients better understand liabilities that could impede a company’s recovery.
GLG strengthens the ability of event-driven funds to evaluate practice-area-box activity, special situations, and associated events. Our Council Members include former senior officials from key antitrust and competitive regulatory bodies at state, federal, and international levels.
GLG’s Legal, Economic, and Regulatory Affairs (LERA) practice area features more than 16,000 former government officials, domestic- and foreign-policy experts, attorneys, economists, and political-risk experts, providing informed assessments of policy debates, new regulations, and geopolitical trends.
GLG’s global in-market coverage teams help emerging and frontier market investors connect to on-the-ground expertise related to industries and companies. Our extensive experience serving emerging market-focused investors and our connections with trusted regional research partners help our clients accurately assess opportunities, risks, and prospects for growth.
We support less-liquid and activist investing strategies through project-based diligence, consulting, and board placement solutions. Our Council Members include industry and operating executives, giving clients an opportunity to leverage a wealth of knowledge, expertise, and senior executive relationships.
We work with asset-based lenders to assess opportunities and build investment conviction through access to industry professionals familiar with target companies and industries and skilled in written analysis, on-site valuation, executive placement, and other elements of post-LOI diligence.
The development of new therapies, devices, and diagnostic tools is driving rapid change in healthcare. GLG helps healthcare investors stay ahead of that change by connecting them with the largest and most varied network of key opinion leaders in biotech and pharmaceuticals, services, and medical devices and diagnostics. Learn More.
+1 212 984 3692
+1 646 616 8913
+44 (0) 207 529 1832
+852 2912 0703
The business world moves fast. Does your research keep pace? By the time you finish reading this post, your company…
Contact us today to get started.
+1 212 880 6524
Thank you for contacting GLG, someone will respond to your inquiry as soon as possible.